Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 754

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 754
---
 investment grade institutions (corporate bonds). The following tables summarize the Company’s available-for-sale marketable securities by major type of security as of September 30, 2024 and December 31, 2023: As of September 30, 2024

| Type of Security                               
 ​                                              | ​     
 Gains | ​ | AmortizedCost |   |     ​ | ​ | ​      
 Losses | ​ | Gross Unrealized |   | ​ |   |   |   |   |   |     |   | ​ | ​ | EstimatedFair Value |   |       |   | ​ |
|:-----------------------------------------------|:------|:--|:--------------|:--|------:|:--|:-------|:--|:-----------------|:--|:--|:--|:--|:--|:--|:--|----:|:--|:--|:--|:--------------------|:--|------:|:--|:--|
| U.S. government agency obligations             | ​     | ​ | ​             | $ | 5,000 | ​ | ​      | ​ | ​                | $ | — | ​ | ​ | ​ | ​ | $ | -25 | ​ | ​ | ​ | ​                   | $ | 4,975 | ​ | ​ |
| Total available-for-sale marketable securities | ​     | ​ | ​             | $ | 5,000 | ​ | ​      | ​ | ​                | $ | — | ​ | ​ | ​ | ​ | $ | -25 | ​ | ​ | ​ | ​                   | $ | 4,975 | ​ | ​ |

As of December 31, 2023

| Type of Security                               
 ​                                              | ​     
 Gains | ​ | AmortizedCost |   |      ​ | ​ | ​      
 Losses | ​ | Gross Unrealized |   | ​ |   |   |   |   |   |      |   | ​ | ​ | EstimatedFair Value |   |        |   | ​ |
|:-----------------------------------------------|:------|:--|:--------------|:--|-------:|:--|:-------|:--|:-----------------|:--|--:|:--|:--|:--|:--|:--|-----:|:--|:--|:--|:--------------------|:--|-------:|:--|:--|
|